Albemarle CorporationALB
NYSE • Basic Materials
$175.96
P/E
—
PEG
—
FCF Yield
—
Rev Growth YoY
-437.0% YoY
Gross Margin
1300.0%
Health Score
3/10
D/E Ratio
0.34
Confidence
LOW
Business Snapshot
Albemarle Corporation is a specialty chemicals company listed on the NYSE, operating primarily in lithium, bromine, and refining solutions markets — making it a key supplier to the electric vehicle battery supply chain. The stock is currently trading at $175.96, sitting near the upper half of its 52-week range of $49.43–$206.00. Market capitalisation data is unavailable in this payload, but based on share price and known float, ALB is broadly considered a large-cap name in the Basic Materials sector.
Financial Health
**Score: 3/10** The financial picture is deeply distorted by extreme margin anomalies and missing core data. A reported gross margin of 1,300% and a net margin of -993% almost certainly reflect data normalisation or one-time accounting items rather than true operating performance, and should not be taken at face value...
Risk Assessment
- **DATA VACUUM:** Core fundamental metrics including P/E ratio, TTM revenue, and free cash flow are unavailable, making rigorous fundamental analysis impossible and materially increasing investment risk. - **GROWTH COLLAPSE:** Revenue declined -437% year-over-year, an extraordinary deterioration that, even if partially attributable to data distortion, signals severe top-line stress. - **PROFITABILITY:** Return on equity of -513% indicates that shareholder equity is being rapidly destroyed, consistent with the -993% net margin reading. - **TECHNICALS:** A death cross pattern (50-day MA crossing below 200-day MA) is active, and the MACD signal is bearish — both are classically negative technical indicators. - **VALUATION PREMIUM WITHOUT EARNINGS SUPPORT:** EV/EBITDA of 32.22x is more than double typical sector norms, and there is no P/E or DCF anchor to justify this premium given current profitability metrics. ---...